UT Southwestern Medical Center ( Site 0190)

Dallas, Texas 75390

2 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Lymphoma, Large B-Cell, Diffuse

Studies at this site

• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009) — Recruiting now
• A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011) — Recruiting now